Markedsdata leveret af TwelveData og Morningstar
Axogen, Inc. is a medical technology company focused on peripheral nerve repair and regeneration. It develops and commercializes surgical solutions designed to restore nerve function after trauma or procedure-related damage, serving surgeons and healthcare providers across reconstructive, orthopedic, oral and maxillofacial, breast reconstruction, and urology procedures. Its current portfolio includes nerve grafts, nerve connectors, nerve protectors, nerve caps, and soft tissue matrices used to repair, protect, and manage peripheral nerves during surgery. Axogen also provides education and support tools that help improve surgical treatment workflows for nerve damage and discontinuity. The company operates in a specialized segment of regenerative medicine and surgical biologics, with products used in hospitals and surgical centers across the United States and select international markets.